申请人:Almirall, S.A.
公开号:US20200255478A1
公开(公告)日:2020-08-13
The invention relates to peptidic compounds, which peptidic compounds are compounds of formula (I)′, or a pharmaceutically acceptable salt, or solvate, or N-oxide, or stereoisomer thereof:
wherein R
1
; R
2
; s; t; u; Aa
78
and G
1
are as defined herein.
The peptidic compounds are useful in activating the Nrf2 pathway.